The New Zealand Meningococcal Vaccine Strategy: A tailor-made vaccine to combat a devastating epidemic

The New Zealand Meningococcal Vaccine Strategy: A tailor-made vaccine to combat a devastating epidemic

Sexton, K. ; Lennon, D. ; Oster, P. ; Crengle, S. ; Martin, D. ; Mulholland, K. ; Percival, T. ; Reid, S. ; Stewart, J. ; O'Hallahan, J.
Identifier: http://hdl.handle.net/2292/4664
Issue Date: 2004
Reference: New Zealand Medical Journal 117 (1200), 2004
Rights: Copyright: New Zealand Medical Association (NZMA)
Rights (URI): https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htm

Abstract:

The New Zealand Meningococcal Vaccine Strategy aims to end the devastating 14-year epidemic of B:4:P1.7b,4 group B meningococcal disease in New Zealand through a mass immunisation programme to all under 20 year olds using a tailor-made vaccine (MeNZBT?). This paper describes the scientific rationale, development, and key components of the New Zealand Meningococcal Vaccine Strategy. A summary of the efficacy and safety data of existing outer membrane vesicle group B meningococcal vaccines is included as these data critically support the Strategy.

Description:

An open access copy of this article is available and complies with the copyright holder/publisher conditions.

Show full item record

Files in this item

Icon
Name: 15475985.pdf
Size: 38.89Kb
Format: PDF
Icon
Related URL: http://www.nzma.org.nz/journal/117-1200/1015/
Find Full text

This item appears in the following Collection(s)

Share

Search ResearchSpace


Browse

Statistics